ArticleBioMed research international2014

Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registry.

E C Inwald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.